The relationship between PD-L1 and the stability of the mRNA of genes involved in the process of cancer progression, such as NBS1 and BRCA1, seems to affect the effectiveness of radiation and chemotherapy; therefore, targeting PD-L1 may increase sensitivity to chemotherapies and radiotherapy [19]. Here, CD274 is linked to cancer.